Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

ProQR Therapeutics N.V. buy Chardan Capital

ProQR Therapeutics N.V.
Start price
€3.10
12.12.24 / 50%
Target price
€3.81
12.12.25
Performance (%)
-37.48%
End price
€1.94
13.12.25
Summary
This prediction ended on 13.12.25 with a price of €1.94. Massive losses of -37.48% were the result for the BUY prediction by Chardan_Capital. Chardan_Capital has a follow-up prediction for ProQR Therapeutics N.V. where he still thinks ProQR Therapeutics N.V. is a Buy. Chardan_Capital has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
ProQR Therapeutics N.V. -4.461% -4.461% -14.390%
iShares Core DAX® -1,86 % 0,67 % 0,92 %
iShares Nasdaq 100 -3,32 % 4,99 % 33,72 %
iShares Nikkei 225® -2,30 % 6,13 % 52,96 %
iShares S&P 500 -1,31 % 3,40 % 24,67 %

Comments by Chardan_Capital for this prediction

In the thread ProQR Therapeutics N.V. diskutieren
Prediction Buy
Perf. (%) -37.48%
Target price 3.814
Change
Ends at 12.12.25

ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat

Chardan Capital 
0
Report Share
12.12.24
In the thread Trading ProQR Therapeutics N.V.
Prediction Buy
Perf. (%) -37.48%
Target price 3.814
Change
Ends at 12.12.25

Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten

Chardan Capital 
0
Report Share
13.12.25

Current prediction by Chardan_Capital for ProQR Therapeutics N.V.

buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.80
08.08.25
€3.43
08.08.26
-26.47%
05.06.26

Chardan Capital 
08.08.25 50%

Stopped prediction by Chardan_Capital for ProQR Therapeutics N.V.

buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.70
09.04.26
€3.43
09.04.27
-22.14%
05.06.26

Chardan Capital 
09.04.26 50%
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€2.05
04.11.25
€3.48
04.11.26
-37.19%
05.06.26

Chardan Capital 
04.11.25 50%
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.59
14.03.25
€3.69
14.03.26
-3.01%
15.03.26

Chardan Capital 
14.03.25 50%
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.86
10.05.24
€2.32
10.05.25
-20.11%
11.05.25

Chardan Capital 
10.05.24 50%
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.27
08.11.23
€1.87
08.11.24
170.93%
09.11.24

Chardan Capital 
08.11.23 50%